1. Home
  2. EPRT vs HALO Comparison

EPRT vs HALO Comparison

Compare EPRT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPRT
  • HALO
  • Stock Information
  • Founded
  • EPRT 2016
  • HALO 1998
  • Country
  • EPRT United States
  • HALO United States
  • Employees
  • EPRT N/A
  • HALO N/A
  • Industry
  • EPRT Real Estate Investment Trusts
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EPRT Real Estate
  • HALO Health Care
  • Exchange
  • EPRT Nasdaq
  • HALO Nasdaq
  • Market Cap
  • EPRT 6.2B
  • HALO 7.4B
  • IPO Year
  • EPRT 2018
  • HALO N/A
  • Fundamental
  • Price
  • EPRT $32.13
  • HALO $52.92
  • Analyst Decision
  • EPRT Buy
  • HALO Buy
  • Analyst Count
  • EPRT 14
  • HALO 9
  • Target Price
  • EPRT $34.84
  • HALO $63.56
  • AVG Volume (30 Days)
  • EPRT 2.1M
  • HALO 2.9M
  • Earning Date
  • EPRT 07-23-2025
  • HALO 08-05-2025
  • Dividend Yield
  • EPRT 3.64%
  • HALO N/A
  • EPS Growth
  • EPRT N/A
  • HALO 55.40
  • EPS
  • EPRT 1.16
  • HALO 3.76
  • Revenue
  • EPRT $475,463,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • EPRT $21.95
  • HALO $25.77
  • Revenue Next Year
  • EPRT $17.02
  • HALO $18.01
  • P/E Ratio
  • EPRT $27.90
  • HALO $14.09
  • Revenue Growth
  • EPRT 25.32
  • HALO 25.64
  • 52 Week Low
  • EPRT $27.28
  • HALO $42.01
  • 52 Week High
  • EPRT $34.88
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • EPRT 45.06
  • HALO 44.94
  • Support Level
  • EPRT $31.20
  • HALO $51.06
  • Resistance Level
  • EPRT $32.39
  • HALO $53.44
  • Average True Range (ATR)
  • EPRT 0.57
  • HALO 1.25
  • MACD
  • EPRT -0.10
  • HALO 0.06
  • Stochastic Oscillator
  • EPRT 33.65
  • HALO 40.97

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: